Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoki Harada

Showing results (91-100 of 261) with videos related to

Pageof 27
Sort By:
Molecular Biology Reports|February 26, 2022
Resistance to obinutuzumab-induced antibody-dependent cellular cytotoxicity caused by abnormal Fas signaling is overcome by combination therapiesNatsumi Kawasaki, Yoriko Yamashita-Kashima, Takaaki Fujimura, et al.
Molecular Nutrition & Food Research|August 28, 2019
Tomatidine Reduces Palmitate-Induced Lipid Accumulation by Activating AMPK via Vitamin D Receptor-Mediated Signaling in Human HepG2 HepatocytesHikari Kusu, Hiroki Yoshida, Michiko Kudo, et al.
Anti-Cancer Drugs|October 22, 2019
Trastuzumab in combination with paclitaxel enhances antitumor activity by promoting apoptosis in human epidermal growth factor receptor 2-positive trastuzumab-resistant gastric cancer xenograft modelsSei Shu, Yoriko Yamashita-Kashima, Mieko Yanagisawa, et al.
Cancer Chemotherapy and Pharmacology|September 30, 2020
Combination efficacy of pertuzumab and trastuzumab for trastuzumab emtansine-resistant cells exhibiting attenuated lysosomal trafficking or efflux pumps upregulationYoriko Yamashita-Kashima, Sei Shu, Masahiro Osada, et al.
Cancer Chemotherapy and Pharmacology|December 18, 2020
Correction to: Combination efficacy of pertuzumab and trastuzumab for trastuzumab emtansine-resistant cells exhibiting attenuated lysosomal trafficking or efflux pumps upregulationYoriko Yamashita-Kashima, Sei Shu, Masahiro Osada, et al.
Acta Medica Okayama|June 22, 2018
R-mini CHP in ≥80-year-old Patients with Diffuse Large B-cell Lymphoma: A Multicenter, Open-label, Single-arm Phase II Trial ProtocolYasuhiko Miyata, Akiko M Saito, Takahiro Yano, et al.
International Journal of Hematology|May 8, 2007
Successful treatment of primary cardiac lymphoma by rituximab-CHOP and high-dose chemotherapy with autologous peripheral blood stem cell transplantationAtsushi Nonami, Katsuto Takenaka, Kenjiro Kamezaki, et al.
The Journal of Biological Chemistry|June 8, 2007
Glyceraldehyde-3-phosphate dehydrogenase enhances transcriptional activity of androgen receptor in prostate cancer cellsNaoki Harada, Ryoko Yasunaga, Yasuki Higashimura, et al.
American Journal of Medical Genetics. Part A|April 1, 2004
9q34.3 deletion syndrome in three unrelated childrenMie Iwakoshi, Nobuhiko Okamoto, Naoki Harada, et al.
The British Journal of Nutrition|November 4, 2020
Oleamide rescues tibialis anterior muscle atrophy of mice housed in small cagesYasuyuki Kobayashi, Natsumi Watanabe, Tomoya Kitakaze, et al.
Pageof 27

Showing results (91-100 of 261) with videos related to

Sort By:
Pageof 27
Molecular Biology Reports|February 26, 2022
Resistance to obinutuzumab-induced antibody-dependent cellular cytotoxicity caused by abnormal Fas signaling is overcome by combination therapiesNatsumi Kawasaki, Yoriko Yamashita-Kashima, Takaaki Fujimura, et al.
Molecular Nutrition & Food Research|August 28, 2019
Tomatidine Reduces Palmitate-Induced Lipid Accumulation by Activating AMPK via Vitamin D Receptor-Mediated Signaling in Human HepG2 HepatocytesHikari Kusu, Hiroki Yoshida, Michiko Kudo, et al.
Anti-Cancer Drugs|October 22, 2019
Trastuzumab in combination with paclitaxel enhances antitumor activity by promoting apoptosis in human epidermal growth factor receptor 2-positive trastuzumab-resistant gastric cancer xenograft modelsSei Shu, Yoriko Yamashita-Kashima, Mieko Yanagisawa, et al.
Cancer Chemotherapy and Pharmacology|September 30, 2020
Combination efficacy of pertuzumab and trastuzumab for trastuzumab emtansine-resistant cells exhibiting attenuated lysosomal trafficking or efflux pumps upregulationYoriko Yamashita-Kashima, Sei Shu, Masahiro Osada, et al.
Cancer Chemotherapy and Pharmacology|December 18, 2020
Correction to: Combination efficacy of pertuzumab and trastuzumab for trastuzumab emtansine-resistant cells exhibiting attenuated lysosomal trafficking or efflux pumps upregulationYoriko Yamashita-Kashima, Sei Shu, Masahiro Osada, et al.
Acta Medica Okayama|June 22, 2018
R-mini CHP in ≥80-year-old Patients with Diffuse Large B-cell Lymphoma: A Multicenter, Open-label, Single-arm Phase II Trial ProtocolYasuhiko Miyata, Akiko M Saito, Takahiro Yano, et al.
International Journal of Hematology|May 8, 2007
Successful treatment of primary cardiac lymphoma by rituximab-CHOP and high-dose chemotherapy with autologous peripheral blood stem cell transplantationAtsushi Nonami, Katsuto Takenaka, Kenjiro Kamezaki, et al.
The Journal of Biological Chemistry|June 8, 2007
Glyceraldehyde-3-phosphate dehydrogenase enhances transcriptional activity of androgen receptor in prostate cancer cellsNaoki Harada, Ryoko Yasunaga, Yasuki Higashimura, et al.
American Journal of Medical Genetics. Part A|April 1, 2004
9q34.3 deletion syndrome in three unrelated childrenMie Iwakoshi, Nobuhiko Okamoto, Naoki Harada, et al.
The British Journal of Nutrition|November 4, 2020
Oleamide rescues tibialis anterior muscle atrophy of mice housed in small cagesYasuyuki Kobayashi, Natsumi Watanabe, Tomoya Kitakaze, et al.
Pageof 27